"May 28, 2010 (New Orleans) -- If your child insists his positive drug test results are a mistake, there's a chance he could be telling the truth.
Drug tests generally produce false-positive results in 5% to 10% of cases and false negati"...
DOSAGE AND ADMINISTRATION
General Dosing Instructions
Carefully consider the potential benefits and risks of DAYPRO ALTA and other treatment options before deciding to use DAYPRO ALTA. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals.
After observing the response to initial therapy with DAYPRO ALTA, the dose and frequency should be adjusted to suit an individual patient’s needs.
Divided doses may be tried in patients unable to tolerate single doses. For osteoarthritis patients of low body weight or with milder disease, an initial dose of one 600 mg tablet once a day may be appropriate. The maximum total daily dose is 1200 mg.
For OA, the dosage is 1200 mg (two 600 mg tablets) given orally once a day.
For RA, the dosage is 1200 mg (two 600 mg tablets) given orally once a day.
Dosage Forms And Strengths
DAYPRO ALTA (oxaprozin potassium) tablets: 600 mg tablets, blue, capsule-shaped, film-coated, with Searle 1391 printed on one side.
Storage And Handling
DAYPRO ALTA 600 mg tablets are blue, capsule-shaped, film-coated, with Searle 1391 printed on one side.
|0025-5500-01||bottle of 100|
|0025-5500-03||bottle of 500|
|0025-5500-02||carton of 100 unit dose|
Store at room temperature 20ºC to 25ºC (68ºF to 77ºF); excursions permitted between 15ºC to 30ºC (59ºF to 86ºF) (see USP Controlled Room Temperature). Dispense in a tightly-closed container. Protect from moisture.
Manufacture by: Pfizer Inc., 235 East 42nd Street, New York, NY, 10017. Revised May 2016This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/21/2016
Additional Daypro Alta Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options